Gene Tan is an associate professor at the J. Craig Venter Institute working in the Infectious Disease group. The focus of his research is on virus-host interactions by defining the immunological, molecular and genetic determinants that govern immunity and disease. The aim is to better understand how viruses manipulate the host machinery to replicate and in turn elucidate the mechanisms by which the host counteracts the pathogen. Analyses of virus-host interaction can then facilitate the development of better diagnostic tools, novel therapeutics and vaccines.

Prior to his appointment at JCVI, Dr. Tan was a postdoctoral fellow at the Icahn School of Medicine at Mount Sinai working on characterizing the immunological and structural determinants of protection against influenza virus and Zika virus. He received his doctorate from Thomas Jefferson University and his undergraduate degree from the Philadelphia College of Pharmacy and Science.

Patents

Vaccines for use in the prophylaxis and treatment of influenza virus disease (Pat. No. US20170114103)

Research Priorities

Characterization of the structural and immunological determinants of protection against viral pathogens:
  • Elucidate the mechanisms by which antibodies neutralize virus and protect in vivo.
  • Emphasis on developing novel methods in isolating monoclonal antibodies from human peripheral blood mononuclear cell (PBMC) compartment.
Characterization of virus-host interaction by defining the molecular and transcriptional response
  • Emphasis on respiratory and neurotropic pathogens.

Genomics of Zika Virus

Investigating the genomics of Zika virus throughout the Americas

Genomics of West Nile Virus

Sequencing West Nile virus genomes isolated in the United States

Genomics of Respiratory Syncytial Virus

Sequencing clinical isolates of Respiratory Syncytial Virus in various locations

Genomics of Influenza A and Influenza B Viruses

Sequencing Influenza genomes isolated from various hosts and locations

Genomics of Rotavirus

Sequencing Rotavirus genomes isolated from around the world

Innovative Research Programs - Viral Genomics
National Immunization Awareness Day
22-Feb-2024
Collaborator Release

New LongCOVID research launched by PolyBio’s global consortium of scientists

Funding will deepen research on the persistence of the SARS-CoV-2 virus in LongCOVID patients and launch new clinical trials

30-Jan-2024
Press Release

J. Craig Venter Institute contracted by the Centers for Disease Control and Prevention to rapidly construct synthetic influenza genes

Genes will be used to help develop seasonal and pandemic vaccines, improving response time and vaccine efficacy

08-Sep-2022
Reuters

Top scientists join forces to study leading theory behind long COVID

Several JCVI scientists will be contributing to the newly launched Long Covid Research Initiative — a collaboration of researchers, clinicians, and patients working to rapidly study and treat long Covid.

13-Jan-2022
Press Release

Omicron and Beta variants evade antibodies elicited by vaccines and previous infections, but boosters help

Pregnancy also contributes to a reduced COVID-19 antibody response

05-Nov-2018
Blog

Fighting Back Against Flu